Skip to main content

Table 2 Age-standardized incidence rate of CV/heart diseases in secondary prevention

From: Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study

Group ASIR of CV/heart disease in 1999 Summary Trend 1 Trend2
AAPC Years APC Years APC
Total 51.7‰ −3.9 [− 7.4; −0.4]* 1999–2001 −13.7 [− 34.4; 13.5] 2001–2013 −2.2 [− 3.8; − 0.6]*
 Women 50.3‰ −2.8 [− 4.5; − 1.1]* 1999–2013 −2.8 [− 4.5; − 1.1]*   
  50–59 34.5‰ −1.2 [− 6.5; 4.4] 1999–2013a −1.2 [− 6.5; 4.4]   
  60–69 33.2‰ − 0.7 [− 3.8; 2.5] 1999–2013 − 0.7 [− 3.8; 2.5]   
  70–79 50.5‰ −3.3 [− 6.7; 0.1] 1999–2013 −3.3 [− 6.7; 0.1]   
  80+ 66.6‰ −3.7 [−5.4; − 2.1]* 1999–2013 −3.7 [− 5.4; − 2.1]*   
 Men 52.8‰ −3.3 [− 5.1; − 1.5]* 1999–2013 −3.3 [− 5.1; − 1.5]*   
  50–59 33.5‰ −1.1 [− 4.9; 2.9] 1999–2013 − 1.1 [− 4.9; 2.9]   
  60–69 51.4‰ − 3.3 [− 5.4; − 1.1]* 1999–2013 − 3.3 [− 5.4; − 1.1]*   
  70–79 58.0‰ −3.7 [− 6.3; − 1.1]* 1999–2013 −3.7 [− 6.3; − 1.1]*   
  80+ 64.1‰ −3.2 [− 5.5; − 0.8]* 1999–2013 −3.2 [− 5.5; − 0.8]*   
  1. *p < 0.05; awithout 2002 because it was 0, ASIR age-standardized incidence rate, AAPC average annual percentage change, APC annual percentage change